Android app on Google Play

UPDATE: BofA/Merrill Lynch Upgrades Mindray Medical (MR) to Buy

December 13, 2013 11:42 AM EST Send to a Friend
Get Alerts MR Hot Sheet
Price: $32.06 +0.22%

Rating Summary:
    4 Buy, 12 Hold, 1 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 8 | Down: 11 | New: 4
Trade MR Now!
Join SI Premium – FREE
(Updated - December 13, 2013 1:03 PM EST)

BofA/Merrill Lynch upgraded Mindray Medical (NYSE: MR) from Neutral to Buy with a price target of $40. The company recently held a conference call to answer questions following a negative report by Ottoman Bay Research. In the view of BofA analysts, Mindray management gave solid information on questions regarding its accounting, cash positions and M&A strategy.

For an analyst ratings summary and ratings history on Mindray Medical click here. For more ratings news on Mindray Medical click here.

Shares of Mindray Medical closed at $35.61 yesterday.




You May Also Be Interested In


Related Categories

Hot Upgrades, Short Sales, Trader Talk, Upgrades

Related Entities

Merrill Lynch, Bank of America

Add Your Comment